Zenotech Laboratories Ltd

Zenotech Laboratories Ltd

₹ 66.0 -0.12%
18 Apr - close price
About

Incorporated in 1989, Zenotech Laboratories Ltd is in the business of manufacturing biotechnology products[1]

Key Points

Business Overview:[1]
ZTLL is a part of Sun Pharmaceuticals Industries Ltd. It does manufacturing and marketing of pharmaceuticals and bio-pharmaceutical products. It is a pharmaceutical specialty
generic injectables company engaged in the area of manufacturing Oncology, bio-technology and General Injectables products

  • Market Cap 403 Cr.
  • Current Price 66.0
  • High / Low 81.0 / 49.6
  • Stock P/E 35.7
  • Book Value 14.2
  • Dividend Yield 0.00 %
  • ROCE 18.4 %
  • ROE 15.1 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 24.4% CAGR over last 5 years
  • Debtor days have improved from 43.2 to 28.6 days.

Cons

  • Stock is trading at 4.66 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
5.64 7.85 9.89 7.98 10.28 8.42 12.37 10.29 8.80 10.98 9.26 11.53 10.94
3.42 4.81 4.28 4.93 4.72 5.19 5.28 5.29 5.22 5.95 5.59 6.01 5.67
Operating Profit 2.22 3.04 5.61 3.05 5.56 3.23 7.09 5.00 3.58 5.03 3.67 5.52 5.27
OPM % 39.36% 38.73% 56.72% 38.22% 54.09% 38.36% 57.32% 48.59% 40.68% 45.81% 39.63% 47.88% 48.17%
0.04 0.34 0.07 0.03 0.04 0.49 0.05 0.65 0.16 0.23 0.20 0.19 0.28
Interest 0.47 0.46 0.46 0.33 0.27 0.15 0.11 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 1.71 1.74 1.72 1.80 1.72 1.73 1.79 1.81 1.80 1.78 1.80 1.81 1.74
Profit before tax 0.08 1.18 3.50 0.95 3.61 1.84 5.24 3.84 1.94 3.48 2.07 3.90 3.81
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% -666.85% 28.05% 28.12% 28.35% -5.17% 29.95% 27.18% 11.55%
0.07 1.18 3.50 0.95 3.61 14.12 3.77 2.77 1.38 3.67 1.44 2.83 3.36
EPS in Rs 0.01 0.19 0.57 0.16 0.59 2.31 0.62 0.45 0.23 0.60 0.24 0.46 0.55
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
2 3 3 4 2 2 11 13 26 22 37 42 43
7 24 20 24 10 13 19 17 17 16 19 22 23
Operating Profit -5 -20 -17 -20 -8 -10 -8 -4 9 6 17 21 19
OPM % -221% -673% -618% -492% -372% -462% -71% -27% 35% 28% 48% 49% 46%
-1 -0 2 0 0 2 2 5 8 0 1 1 1
Interest 1 1 5 7 8 8 2 0 1 2 1 0 0
Depreciation 3 4 4 4 4 4 4 4 5 6 7 7 7
Profit before tax -10 -26 -23 -30 -19 -20 -12 -3 11 -1 10 15 13
Tax % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% -124% 20%
-10 -26 -23 -30 -19 -20 -12 -3 11 -1 22 12 11
EPS in Rs -1.68 -4.18 -3.75 -4.99 -3.14 -3.26 -1.94 -0.51 1.77 -0.20 3.63 1.90 1.85
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 30%
5 Years: 31%
3 Years: 18%
TTM: 7%
Compounded Profit Growth
10 Years: 9%
5 Years: 24%
3 Years: 38%
TTM: -49%
Stock Price CAGR
10 Years: 10%
5 Years: 24%
3 Years: 18%
1 Year: 25%
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 18%
Last Year: 15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 34 34 34 34 34 34 61 61 61 61 61 61 61
Reserves 17 -8 -31 -62 -80 -100 -19 -22 -11 -13 10 21 26
5 16 47 54 54 54 0 20 21 21 6 0 0
12 25 20 37 45 62 40 25 15 17 17 19 17
Total Liabilities 68 67 70 64 53 51 82 85 86 86 94 101 104
62 59 56 52 48 47 44 43 49 74 71 65 68
CWIP 0 0 0 0 0 0 2 17 29 2 0 5 1
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
6 8 14 12 5 4 35 25 8 9 23 31 35
Total Assets 68 67 70 64 53 51 82 85 86 86 94 101 104

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-2 -10 -24 -8 -5 2 -16 -14 11 6 18 21
-0 -0 -0 0 6 -1 -3 -16 -21 -5 -2 -6
2 10 30 7 -1 -1 47 15 -3 0 -16 -6
Net Cash Flow 0 -0 5 -1 -0 0 28 -15 -12 1 -0 9

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 12 8 12 36 62 0 0 66 26 62 39 29
Inventory Days 82 375 562 233 305 202 374 294
Days Payable 650 732 488 222 816 1,128 2,468 2,089
Cash Conversion Cycle -556 -348 86 46 -449 -926 -2,094 -1,728 26 62 39 29
Working Capital Days -2,280 -2,916 -2,417 -3,295 -8,062 -10,395 -1,219 -537 -171 -164 -106 -99
ROCE % -13% -48% -39% -62% -66% -62% -6% 8% 0% 15% 18%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
68.84% 68.84% 68.84% 68.84% 68.84% 68.84% 68.84% 68.84% 68.84% 68.84% 68.84% 68.84%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.98% 0.98% 0.98% 0.98% 0.98% 0.98% 0.98%
31.15% 31.15% 31.15% 31.15% 31.15% 30.18% 30.17% 30.17% 30.18% 30.17% 30.17% 30.17%
No. of Shareholders 6,7647,2997,5667,7608,0147,9308,7469,1429,2499,5899,7629,819

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents